A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Stock has been beat down in the last few months over weak Fotlyn sales. Some management positions have been made and this company is gearing up to increase sales in both North America and Europe. Also, at these prices a buyout is possible.